Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the current study is to investigate if a drug-drug interaction occurs with
the administration of omeprazole 80 mg q.d. at steady state on the pharmacokinetics of
dipyridamole and the pharmacodynamics of ASA-induced platelet aggregation inhibition
(components of Aggrenox®) when administered every 12 hours at steady state.